CHARACTERIZATION OF THE INTERLEUKIN-2 RECEPTORS (IL-2R) EXPRESSED ON HUMAN NATURAL-KILLER-CELLS ACTIVATED INVIVO BY IL-2 - ASSOCIATION OF THE P64 IL-2R GAMMA-CHAIN WITH THE IL-2R BETA-CHAIN IN FUNCTIONAL INTERMEDIATE-AFFINITY IL-2R

被引:147
作者
VOSS, SD
SONDEL, PM
ROBB, RJ
机构
[1] UNIV WISCONSIN,CTR CLIN SCI,DEPT PEDIAT,MADISON,WI 53792
[2] UNIV WISCONSIN,CTR CLIN SCI,DEPT GENET,MADISON,WI 53792
[3] DUPONT MERK PHARMACEUT CO,WILMINGTON,DE 19880
关键词
D O I
10.1084/jem.176.2.531
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin 2 (IL-2) receptors expressed on the surface of activated T cells and natural killer (NK) cells exhibit a variety of affinity states depending on their subunit composition. Low-affinity binding is associated with a 55-kD alpha-chain, intermediate-affinity binding with a 70-75-kD beta-chain, and high-affinity binding with a bimolecular complex of the alpha and beta-subunits. In a previous study of the IL-2 receptors expressed on NK cells obtained from cancer patients after in vivo IL-2 therapy, we documented a discrepancy between the level of beta-chain and the level of intermediate-affinity IL-2 binding sites expressed on the cell surface. Based on this result, we postulated that formation of intermediate-affinity receptor sites required a component in addition to the beta-chain, and that this component was present at limiting levels in the patient NK cells. In the present study we have examined the structure of the intermediate-affinity receptor complex using monoclonal antibodies that recognize the beta-chain, but that do not interfere with its ability to bind IL-2. Evidence is presented establishing the physical association of a novel protein of 64 kD with the beta-chain in intermediate-affinity IL-2 binding sites. This molecule, termed IL-2R gamma-chain, coprecipitated with beta-chains prepared from cells that had been incubated with IL-2, but was undetectable in immunoprecipitates prepared in the absence of IL-2. Examination of gamma-chain expression in post-IL-2 therapy NK cells, where only low levels of intermediate-affinity IL-2 binding were detectable, revealed that the gamma-chain was associated with, on average, only 10-12% of the beta-chains expressed on such cells. This contrasted with approximately equal levels of beta and gamma-chain expression on YT cells, a cell line that has both high levels of cell surface beta-chain expression and high levels of IL-2 binding. Thus, the ratio of gamma-chain to beta-chain present in the immunoprecipitates roughly correlated with the proportion of beta-chain involved in intermediate-affinity receptor sites. This result suggests that the 64-kD gamma-chain is the component responsible for regulating the affinity of IL-2 association with the beta-subunit. By further defining the structural components necessary for IL-2 receptor formation, these studies provide additional insight into mechanisms whereby lymphocytes might regulate their responsiveness to IL-2.
引用
收藏
页码:531 / 541
页数:11
相关论文
共 55 条
  • [1] FC-GAMMA RECEPTOR TYPE-III (CD16) IS INCLUDED IN THE ZETA-NK RECEPTOR COMPLEX EXPRESSED BY HUMAN NATURAL-KILLER-CELLS
    ANDERSON, P
    CALIGIURI, M
    OBRIEN, C
    MANLEY, T
    RITZ, J
    SCHLOSSMAN, SF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (06) : 2274 - 2278
  • [2] THE EVIDENCE FOR THE IL-2 RECEPTOR-BETA CHAIN PROCESSING FROM P70 TO P75
    ASAO, H
    TAKESHITA, T
    NAKAMURA, M
    NAGATA, K
    SUGAMURA, K
    [J]. INTERNATIONAL IMMUNOLOGY, 1990, 2 (05) : 469 - 472
  • [3] INTERLEUKIN-2 (IL-2)-INDUCED TYROSINE PHOSPHORYLATION OF IL-2 RECEPTOR-P75
    ASAO, H
    TAKESHITA, T
    NAKAMURA, M
    NAGATA, K
    SUGAMURA, K
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (03) : 637 - 644
  • [4] SERUM CD25 LEVELS DURING INTERLEUKIN-2 THERAPY - DOSE DEPENDENCE AND CORRELATIONS WITH CLINICAL TOXICITY AND LYMPHOCYTE SURFACE SCD25 EXPRESSION
    BOGNER, MP
    VOSS, SD
    BECHHOFER, R
    HANK, JA
    ROPER, M
    POPLACK, D
    HAMMOND, D
    SONDEL, PM
    [J]. JOURNAL OF IMMUNOTHERAPY, 1992, 11 (02): : 111 - 118
  • [5] COLAMONICI OR, 1990, J IMMUNOL, V145, P155
  • [6] A NEW CYTOKINE RECEPTOR SUPERFAMILY
    COSMAN, D
    LYMAN, SD
    IDZERDA, RL
    BECKMANN, MP
    PARK, LS
    GOODWIN, RG
    MARCH, CJ
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1990, 15 (07) : 265 - 270
  • [7] A 2ND HUMAN INTERLEUKIN-2 BINDING-PROTEIN THAT MAY BE A COMPONENT OF HIGH-AFFINITY INTERLEUKIN-2 RECEPTORS
    DUKOVICH, M
    WANO, Y
    THUY, LTB
    KATZ, P
    CULLENS, BR
    KEHRL, JH
    GREENE, WC
    [J]. NATURE, 1987, 327 (6122) : 518 - 522
  • [8] FARRAR WL, 1989, J BIOL CHEM, V264, P12562
  • [9] CO-INTERNALIZATION OF THE P55 AND P70 SUBUNITS OF THE HIGH-AFFINITY HUMAN INTERLEUKIN-2 RECEPTOR - EVIDENCE FOR A STABLE TERNARY RECEPTOR COMPLEX
    FUNG, MR
    JU, G
    GREENE, WC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (05) : 1923 - 1928
  • [10] FUNG MR, 1991, J IMMUNOL, V147, P1253